Feeling Stuck on Antidepressants in Midlife? How to Taper Off Safely with Mark Horowitz, PhD
Why It Matters
Understanding the limited biological basis and withdrawal risks of long‑term antidepressant use prompts safer prescribing and empowers patients to discontinue safely, reducing widespread emotional numbing.
Key Takeaways
- •One‑third of women 40‑60 use antidepressants long‑term regularly
- •No solid evidence links depression to serotonin deficiency
- •Antidepressants cause emotional numbing, flattening both positive and negative feelings
- •Physical dependence can trigger withdrawal symptoms like anxiety, irritability, suicidality
- •Gradual tapering with clinician oversight reduces risk of severe withdrawal
Summary
The discussion centers on the widespread, often long‑term use of antidepressants among mid‑life women, questioning the prevailing serotonin‑deficiency narrative and featuring deprescribing expert Dr. Mark Horowitz.
Horowitz cites striking statistics—56 million Americans on antidepressants, 25 million for over five years—and explains that these drugs produce emotional numbing and physical dependence, leading to withdrawal symptoms such as anxiety, irritability, and suicidality when stopped abruptly.
He critiques campaigns like the UK’s “Defeat Depression,” which medicalized normal stress responses and spurred an eight‑fold rise in prescriptions, noting many prescriptions address menopausal or life‑event‑related mood changes rather than true clinical depression.
The implication is clear: clinicians should treat antidepressants as short‑term crisis interventions, evaluate patients’ life context, and employ slow, supervised tapering protocols to avoid relapse and withdrawal, thereby restoring patients’ full emotional range.
Comments
Want to join the conversation?
Loading comments...